{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T04:16:20Z","timestamp":1778991380713,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":586,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.bbmt.2013.06.015","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T07:22:12Z","timestamp":1372144932000},"page":"1361-1367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"19","author":[{"given":"Parameswaran","family":"Hari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd E.","family":"DeFor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Vesole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher N.","family":"Bredeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.06.015_bib1","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1210\/jc.2006-2870","article-title":"Bone loss and its management in long-term survivors from allogeneic stem cell transplantation","volume":"92","author":"Tauchmanova","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bbmt.2013.06.015_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.bmt.1705918","article-title":"High prevalence of early-onset osteopenia\/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy","volume":"41","author":"Yao","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bbmt.2010.02.017","article-title":"Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation","volume":"16","author":"Yao","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1359\/jbmr.1999.14.3.342","article-title":"Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation","volume":"14","author":"Ebeling","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.bbmt.2013.06.015_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1083-8791(00)70039-5","article-title":"Mechanisms of osteoporosis after hematopoietic cell transplantation","volume":"6","author":"Weilbaecher","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/bbmt.2001.v7.pm11400947","article-title":"Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study","volume":"7","author":"Stern","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.bmt.1703317","article-title":"Recovery of bone mass and\u00a0normalization of bone turnover in long-term survivors of allogeneic bone marrow transplantation","volume":"29","author":"Kananen","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1083-8791(00)70061-9","article-title":"Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study","volume":"6","author":"Kashyap","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s001980070124","article-title":"Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study","volume":"11","author":"Schulte","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bbmt.2013.06.015_bib10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1046\/j.1365-2141.2003.04303.x","article-title":"Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study","volume":"121","author":"Gandhi","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.06.015_bib11","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.leu.2402264","article-title":"Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis","volume":"15","author":"Massenkeil","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2013.06.015_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1701586","article-title":"A\u00a0prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin","volume":"23","author":"Valimaki","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bmt.1705196","article-title":"Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation","volume":"37","author":"Tauchmanova","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2004-0509","article-title":"Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation","volume":"90","author":"Tauchmanova","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bbmt.2013.06.015_bib15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00198-003-1520-2","article-title":"Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies","volume":"14","author":"Tauchmanova","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bbmt.2013.06.015_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/bmt.2008.414","article-title":"Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients","volume":"44","author":"Chae","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib17","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1210\/jc.2006-0684","article-title":"Pamidronate reduces bone loss after allogeneic stem cell transplantation","volume":"91","author":"Grigg","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bbmt.2013.06.015_bib18","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1445-5994.2006.01154.x","article-title":"Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation","volume":"36","author":"D'Souza","year":"2006","journal-title":"Intern Med J"},{"key":"10.1016\/j.bbmt.2013.06.015_bib19","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/jc.2004-2161","article-title":"Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate","volume":"90","author":"Kananen","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bbmt.2013.06.015_bib20","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/S0149-2918(03)80327-2","article-title":"Zoledronic acid: a new parenteral bisphosphonate","volume":"25","author":"Li","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.bbmt.2013.06.015_bib21","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2013.06.015_bib22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/AOG.0b013e3181bdce0a","article-title":"Zoledronic acid for the prevention of bone loss in postmenopausal women with low bone mass: a randomized controlled trial","volume":"114","author":"McClung","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bbmt.2013.06.015_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2013.06.015_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-200124010-00003","article-title":"Anticancer drug-induced kidney disorders","volume":"24","author":"Kintzel","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.bbmt.2013.06.015_bib25","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/0091270002239824","article-title":"The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function","volume":"43","author":"Skerjanec","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.bbmt.2013.06.015_bib26","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.06.015_bib27","unstructured":"Snedecor G, Cochran W. Statistical Methods (eighth ed.), Iowa.\u00a01989."},{"key":"10.1016\/j.bbmt.2013.06.015_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2013.06.015_bib29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","article-title":"Non-parametric inference for cumulative incidence functions in competing risks studies","volume":"16","author":"Lin","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2013.06.015_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbmt.2007.02.001","article-title":"Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease","volume":"13","author":"Carpenter","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1399-0012.2011.01527.x","article-title":"Prophylactic use of zoledronic acid to prevent early bone loss is safe and feasible in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation","volume":"26","author":"Ganguly","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bbmt.2013.06.015_bib32","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K","article-title":"High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia","volume":"92","author":"Banfi","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2013.06.015_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1210\/jcem.87.1.8135","article-title":"The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells","volume":"87","author":"Lee","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bbmt.2013.06.015_bib34","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1210\/jc.2002-020800","article-title":"Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in\u00a0vitro growth of marrow stromal cells after allogeneic stem cell transplantation","volume":"87","author":"Tauchmanova","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.bbmt.2013.06.015_bib35","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1001\/jama.2011.1558","article-title":"Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies","volume":"306","author":"Sorror","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2013.06.015_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbmt.2009.02.007","article-title":"Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences","volume":"15","author":"Sorror","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113002863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113002863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:44:44Z","timestamp":1761057884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113002863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1083879113002863"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.06.015","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermittent Zoledronic Acid Prevents Bone Loss in Adults after Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}